- This event has passed.
Event Date: July 11, 2018, 12:00-1:00pm ET
Registration Deadline: July 10, 2018
Member: $15 | Nonmember: $75
This program is accredited to provide 1.0 ACRP contact hour.
Member: $0 | Nonmember: N/A
FDA regulations and the Common Rule share the same definition for “minimal risk,” but while the Common Rule allows a waiver of informed consent for minimal risk research if specific criteria are met current FDA regulations do not. FDA indicates that waiver of informed consent for certain FDA-regulated minimal risk clinical investigations will facilitate investigators’ ability to conduct studies that may contribute substantially to the development of products to diagnose or treat diseases or conditions, or address unmet medical needs. FDA intends to revise its informed consent regulations in response the 21st Century Cures Act. Learn what the FDA is requiring, via recent Guidance in order for minimal risk research to be conducted with an alteration or waiver of informed consent. Be sure you are prepared for the new opportunities this policy change will open to your research teams.
Upon completion of this Webinar, attendees should be able to:
We are using cookies to give you the best experience on our website.
You can find out more about which cookies we are using or switch them off in settings.
You can adjust all of your cookie settings by navigating the tabs on the left hand side.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.